Skip to main content
Premium Trial:

Request an Annual Quote

Ariana Pharma, CTCLS Ink Distribution Deal for Japan

NEW YORK (GenomeWeb News) – Ariana Pharma announced today an exclusive distribution deal with CTC Laboratory Systems covering Japan.

The terms of the deal call for CTCLS to distribute Ariana's KEM data analytics software and services technology. CTCLS, based in Tokyo, is an R&D service provider, specializing in the pharmaceutical sector.

Further details of the deal were not disclosed.

KEM, short for Knowledge Extraction and Management, is an association rules-based data analytical technology. It finds patient responder "subpopulations and biomarker signatures that statistical methods are unable to detect," according to Ariana, which has offices in Paris and in Cambridge, Mass.

"This deal with CTCLS will provide an excellent entry into Asia and the world's third largest biotechnology market," Mohammad Afshar, president and CEO of Ariana, said in a statement. "We expect the ongoing growth of Japanese companies in medicine development, diagnostics, and biomarker studies will further increase demand for Ariana’s KEM software."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.